News

Inozyme Pharma nabs $49 mln Series A

Inozyme Pharma Inc, a developer of treatments for rare diseases of calcification, affecting soft tissues and bone, has raised $49 million in Series A financing. Longitude Capital led the round with participation from other investors that included New Enterprise Associates, Novo Ventures and Sanofi Ventures.

Catalia Health bags $4 mln

San Francisco-based Catalia Health, a provider of an AI-powered patient engagement platform, has raised $4 million in funding. Ion Pacific led the round.

Battery, DFJ, GGV at the front of newly minted venture portfolio

Stock index of venture-backed listings inches up a little

Health IQ raises $34.6 mln for life insurance for the health-conscious

Flying Fish raises $2.5 mln for its coffers

Seattle-based Flying Fish Venture Partners has raised $2.5 million for its inaugural fund, Flying Fish Fund I, according to a regulatory filing. The target fund size is not known, but the firm raised the commitments from 13 investors, according to the reg filing. The firm, founded by a team of Seattle angel investors, invests in Pacific Northwest startups in cloud computing, artificial intelligence, speech and natural language, machine learning and Internet of Things, according to its website. The listed partners are Geoff Harris, Heather Redman and Frank Chang.

Sure Ventures seeks to raise undisclosed fund size

Sure Ventures, a San Francisco-based firm focused on early-stage insurtech deals, filed a regulatory document seeking to raise its inaugural fund. A target amount was not listed. The firm is led by Gopinath Rangan, a co-founder of INSEAD Angels and an adviser with Village Capital and Plug and Play Tech Center, according to his LinkedIn.

EBR Systems amasses $50 mln

Sunnyvale, California-based EBR Systems Inc, a wireless cardiac pacing system provider for heart failure, has raised $50 million in funding. M.H. Carnegie & Co. and Brandon Capital Partners led the round with participation from other backers that included Split Rock Partners, Ascension Ventures and Emergent Medical Partners.

Base10 Partners changes fund name, raises $83.8 mln

Base10 Partners has raised $83.8 million toward a $125 million target for its first fund, according to a regulatory filing. The fund, Base10 Partners I, was previously known as Urizen Early Stage Ventures II, and has secured commitments from 12 investors, according to the filing. The San Francisco firm is led by Adeyemi Ajao and TJ Nahigian. Base10 focuses on investing in companies working with automation and intelligent software, according to its website.

Sequoia to raise third scout fund

Sequoia Capital has set out to raise a third scout fund, according to a filing with the SEC.